ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.24
-0.72 (-5.16%)
Jun 13, 2025, 4:08 PM HKT

HKG:1541 Statistics

Total Valuation

HKG:1541 has a market cap or net worth of HKD 5.69 billion. The enterprise value is 5.03 billion.

Market Cap 5.69B
Enterprise Value 5.03B

Important Dates

The last earnings date was Monday, May 26, 2025.

Earnings Date May 26, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:1541 has 407.31 million shares outstanding. The number of shares has increased by 4.24% in one year.

Current Share Class 396.28M
Shares Outstanding 407.31M
Shares Change (YoY) +4.24%
Shares Change (QoQ) +1.60%
Owned by Insiders (%) 17.27%
Owned by Institutions (%) 17.52%
Float 253.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 67.18
PB Ratio 7.88
P/TBV Ratio 7.87
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -14.97
EV / Sales 59.43
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -34.14

Financial Position

The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.20.

Current Ratio 4.04
Quick Ratio 3.50
Debt / Equity 0.20
Debt / EBITDA n/a
Debt / FCF -0.98
Interest Coverage -89.31

Financial Efficiency

Return on equity (ROE) is -44.38% and return on invested capital (ROIC) is -23.51%.

Return on Equity (ROE) -44.38%
Return on Assets (ROA) -21.43%
Return on Invested Capital (ROIC) -23.51%
Return on Capital Employed (ROCE) -43.55%
Revenue Per Employee 542,564
Profits Per Employee -2.15M
Employee Count 156
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.44% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -9.44%
50-Day Moving Average 8.38
200-Day Moving Average 6.61
Relative Strength Index (RSI) 63.58
Average Volume (20 Days) 7,887,378

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:1541 had revenue of HKD 84.64 million and -336.12 million in losses. Loss per share was -0.89.

Revenue 84.64M
Gross Profit 84.64M
Operating Income -327.81M
Pretax Income -336.91M
Net Income -336.12M
EBITDA -316.87M
EBIT -327.81M
Loss Per Share -0.89
Full Income Statement

Balance Sheet

The company has 800.39 million in cash and 145.11 million in debt, giving a net cash position of 655.28 million or 1.61 per share.

Cash & Cash Equivalents 800.39M
Total Debt 145.11M
Net Cash 655.28M
Net Cash Per Share 1.61
Equity (Book Value) 721.83M
Book Value Per Share 1.77
Working Capital 695.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -136.25 million and capital expenditures -11.07 million, giving a free cash flow of -147.32 million.

Operating Cash Flow -136.25M
Capital Expenditures -11.07M
Free Cash Flow -147.32M
FCF Per Share -0.36
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -387.30%
Pretax Margin -398.05%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:1541 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.24%
Shareholder Yield n/a
Earnings Yield -5.91%
FCF Yield -2.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:1541 has an Altman Z-Score of 9.38 and a Piotroski F-Score of 2.

Altman Z-Score 9.38
Piotroski F-Score 2